PEAK6
NVO

PEAK6’s Novo Nordisk NVO Stock Holding History

PEAK6’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.45M Buy
148,400
+39,900
+37% +$1.89M 0.01% 859
2025
Q4 		$5.52M Sell
108,500
-42,500
-28% -$2.17M 0.01% 899
2025
Q3 		$8.38M Buy
151,000
+21,800
+17% +$1.28M 0.01% 773
2025
Q2 		$8.92M Buy
129,200
+15,000
+13% +$1.02M 0.02% 681
2025
Q1 		$7.93M Buy
114,200
+114,100
+114,100% +$9.42M 0.02% 684
2024
Q4 		$8.6K Buy
+100
New +$10.8K ﹤0.01% 2936

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

PEAK6's NVO Position: Q1 2026 in Review

PEAK6 reduced its Novo Nordisk (NVO) stake by 1.1% in Q1 2026, selling an estimated $83.7K and leaving 156,695 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #831.

PEAK6 first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $17.8M in Q1 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • PEAK6 held 156,695 shares of Novo Nordisk worth $5.76M as of Q1 2026.
  • PEAK6 sold 1,767 Novo Nordisk shares in Q1 2026, an estimated $83.7K.
  • Novo Nordisk made up 0.01% of PEAK6's portfolio in Q1 2026, its #831 holding.
  • PEAK6 first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Novo Nordisk position peaked at $17.8M in Q1 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.